Global Single-cell Analysis Market

Published by

Akash Raskar activities: Research

Jul 15, 2021

 


The Global Single-cell Analysis Market was valued at $763.4 Mn in 2020 and is expected to reach $2005 Mn by 2026, at a CAGR of 17.1%.
Market Introduction and Overview

Single-cell analysis is a complex technology that allows the analysis of single cells from a mixture of cells. This type of analysis provides the basis for understanding the complex system in fields like neurology, cancer, and stem cell biology.

Various technologies are used in single-cell analysis. The last several years have seen the rapid development of technologies and methods that permit a detailed analysis of the genome and transcriptome of a single cell. These emerging technologies provide an unprecedented opportunity to capture new biological processes and mechanisms at the single-cell level. Expanding technological innovations, rising prevalence of chronic diseases worldwide and rising government funds for research and development activities are driving the single-cell analysis market.

The increasing demand for personalized medicines and growing biopharmaceutical industries are key drivers to the market.

Increasing collaborations, partnerships, and product launches between key players are boosting the market. The collaborations and partnerships majorly focus on new and innovative products, improving geographical presence, and purchasing single-cell analysis products. Over recent years, single-cell sequencing has become a method of choice in many areas of biomedical research due to its ability to provide information about the molecular state of all the cell types and thousands of individual cells in a sample. These techniques are developing rapidly to improve their sensitivity and scalability and to reduce the price, time, and resources required to carry out single-cell sequencing studies. The market for single-cell analysis is still at a beginning stage as compared to the genomics and sequencing market.

However some players such as Bio-Rad and Illumina is investing in the development, thereby driving the market.
The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in Single cell analysis Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.

The report has profiled more than twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Global Single-cell Analysis Market Segment Analysis

The research applications segment held the maximum share, owing to the high prevalence of cancer, and the increasing need for stem cell research, initiatives for early detection of chronic diseases, and increasing awareness regarding commercially available cancer diagnostics. In the research segment, cancer and immunology is of growing interest among the scientific communities. According to cancer.gov, 1.8 million people were estimated to be diagnosed with cancer for the year 2019. With this sort of prevalence of cancers, there is a high requirement of analysis of the cancer cells, which is boosting the market.

Immunology studies aid in the early detection of therapeutic complications including many cancer and haematology based indications and increase the efficiency of the treatment. Furthermore, invasion of the metabolic activities of single cells is increasing the adoption of its analytical tools, thus propelling the growth of the research segment.
The next-generation sequencing segment accounted for the highest CAGR.

Based on technique, the APAC single-cell analysis market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, microscopy, mass spectrometry, and other techniques. In 2019, the next-generation sequencing segment accounted for the highest growth rate. The advancements in NGS techniques and their wide application in drug discovery for cancer are the major factors driving this segments growth.

To know about the Research Methodology :- Request Free Sample Report
Global Single-cell Analysis Market Market Segmentation

Global Single-cell Analysis Market, By Product

• Consumables
 Beads
 Microplates
 Reagents
 Assay Kits
 Immunoassays
 Cell-based Assays
• Instruments
 Flow Cytometers
 NGS Systems
 PCR Instruments
 Spectrophotometers
Global Single-cell Analysis Market, By Cell Type

• Human Cells
• Animal Cells
• Microbial Cells
Global Single-cell Analysis Market,By Technique

• Flow Cytometry
• Next-generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
Global Single-cell Analysis Market, By Application

• Research Applications
• Medical Applications
Global Single-cell Analysis Market Regional Insights

North America accounted for the largest share of xx% in 2020, reason being the rising prevalence of diseases and also the rising geriatric population. In recent years, several government initiatives have been launched that are supplementing the growth of the single cell analysis market in the region. Well-established healthcare infrastructure, ease of availability is also a key driver affecting the market growth. Investments by key players in this field has boosted the market growth. Rising adoption of technologically advanced diagnostic imaging systems for lymphedema is rapidly growing the market.

Asia Pacific is also expected to witness significant growth during the forecast period due to the increasing geriatric population and rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.
Scope of report :Inquire before Buying

The single-cell analysis market is expanding globally due to the increasingly advanced technology in the single-cell analysis products. The major factors accelerating the single-cell analysis market include rapidly increasing chronic diseases and cancer cases all over the world, increasing biotechnology & biopharmaceutical industries, and life science research. Although, due to high competition, the endurance of new entrants and small players is difficult in the market, and is a challenge for market growth. The emerging markets in Asia are expected to provide future opportunities for the market.


Key Players operating the Global Single-cell Analysis Market

• Becton
• Dickinson and Company
• Danaher Corporation
• Merck Millipore
• QIAGEN
• Thermo Fisher Scientific
• General Electric Company
• 10x Genomics
• Promega Corporation
• Illumina
• Bio-Rad Laboratories
• Fluidigm Corporation
• Agilent Technologies
• NanoString Technologies
• Tecan Group
• Sartorius AG
• Luminex Corporation
• Takara Bio
• Fluxion Biosciences
• Menarini Silicon Biosystems
• LumaCyte

The report also helps in understanding Global Single-cell Analysis Market dynamics, structure by analysing the market segments and project the Global Single-cell Analysis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Single-cell Analysis Market make the report investor’s guide.

About This Report

 

Visit @:
This Report Is Submitted By : Maximize Market Research Company
About Us:
Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

 


Articles authored by  Akash Raskar

Published: Jul 15, 2021

Published: Jul 15, 2021

Published: Jul 15, 2021

Published: Jul 15, 2021

Published: Jul 15, 2021